Study # BN012

A Randomized Phase III Trial of Pre-Operative Compared to Post-Operative Stereotactic Radiosurgery in Patients with Resectable Brain Metastases

Study Status:

Enrolling

Treatment Agent:

Not Applicable

Description

Short Title: BN012

This phase III trial compares the addition of stereotactic radiosurgery before or after surgery in treating patients with cancer that has spread to the brain (brain metastases). Stereotactic radiosurgery is a type of radiation therapy that delivers a high dose of radiation only to the small areas of cancer in the brain and avoids the surrounding normal brain tissue. Surgery and radiation may stop the tumor from growing for a few months or longer and may reduce symptoms of brain metastases.

Resources and Links

National Clinical Trial Identified Number: NCT05438212

Information and next steps

Disease:

  • Metastatic Malignant Neoplasm in the Brain,
  • Brain Cancer

Study Phase:

III

Physician Name:

Department:

Ask a Question